vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and GULFPORT ENERGY CORP (GPOR). Click either name above to swap in a different company.

GULFPORT ENERGY CORP is the larger business by last-quarter revenue ($398.2M vs $284.0M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 33.3%, a 63.1% gap on every dollar of revenue. On growth, GULFPORT ENERGY CORP posted the faster year-over-year revenue change (66.0% vs 9.4%). Over the past eight quarters, GULFPORT ENERGY CORP's revenue compounded faster (18.6% CAGR vs 17.5%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Gulfport Energy Corp is a U.S.-headquartered independent oil and natural gas exploration and production company. It primarily operates in onshore resource basins including Ohio's Utica Shale and Oklahoma's SCOOP play, producing natural gas, crude oil, and natural gas liquids to supply North American industrial, utility, and commercial end markets.

ACAD vs GPOR — Head-to-Head

Bigger by revenue
GPOR
GPOR
1.4× larger
GPOR
$398.2M
$284.0M
ACAD
Growing faster (revenue YoY)
GPOR
GPOR
+56.6% gap
GPOR
66.0%
9.4%
ACAD
Higher net margin
ACAD
ACAD
63.1% more per $
ACAD
96.3%
33.3%
GPOR
Faster 2-yr revenue CAGR
GPOR
GPOR
Annualised
GPOR
18.6%
17.5%
ACAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
GPOR
GPOR
Revenue
$284.0M
$398.2M
Net Profit
$273.6M
$132.4M
Gross Margin
90.8%
76.6%
Operating Margin
6.1%
44.9%
Net Margin
96.3%
33.3%
Revenue YoY
9.4%
66.0%
Net Profit YoY
90.3%
148.5%
EPS (diluted)
$1.61
$7.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
GPOR
GPOR
Q4 25
$284.0M
$398.2M
Q3 25
$278.6M
$379.7M
Q2 25
$264.6M
$447.6M
Q1 25
$244.3M
$197.0M
Q4 24
$259.6M
$239.9M
Q3 24
$250.4M
$253.9M
Q2 24
$242.0M
$181.1M
Q1 24
$205.8M
$283.2M
Net Profit
ACAD
ACAD
GPOR
GPOR
Q4 25
$273.6M
$132.4M
Q3 25
$71.8M
$111.4M
Q2 25
$26.7M
$184.5M
Q1 25
$19.0M
$-464.0K
Q4 24
$143.7M
$-273.2M
Q3 24
$32.8M
$-14.0M
Q2 24
$33.4M
$-26.2M
Q1 24
$16.6M
$52.0M
Gross Margin
ACAD
ACAD
GPOR
GPOR
Q4 25
90.8%
76.6%
Q3 25
92.2%
74.6%
Q2 25
92.2%
80.7%
Q1 25
91.7%
57.9%
Q4 24
91.6%
63.2%
Q3 24
92.5%
64.6%
Q2 24
92.5%
52.2%
Q1 24
88.8%
69.4%
Operating Margin
ACAD
ACAD
GPOR
GPOR
Q4 25
6.1%
44.9%
Q3 25
12.8%
41.9%
Q2 25
12.2%
56.0%
Q1 25
7.9%
6.1%
Q4 24
59.1%
-131.3%
Q3 24
12.6%
5.7%
Q2 24
12.6%
-10.0%
Q1 24
7.4%
28.9%
Net Margin
ACAD
ACAD
GPOR
GPOR
Q4 25
96.3%
33.3%
Q3 25
25.8%
29.3%
Q2 25
10.1%
41.2%
Q1 25
7.8%
-0.2%
Q4 24
55.4%
-113.9%
Q3 24
13.1%
-5.5%
Q2 24
13.8%
-14.5%
Q1 24
8.0%
18.4%
EPS (diluted)
ACAD
ACAD
GPOR
GPOR
Q4 25
$1.61
$7.98
Q3 25
$0.42
$4.45
Q2 25
$0.16
$9.12
Q1 25
$0.11
$-0.07
Q4 24
$0.86
$-14.72
Q3 24
$0.20
$-0.83
Q2 24
$0.20
$-1.51
Q1 24
$0.10
$2.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
GPOR
GPOR
Cash + ST InvestmentsLiquidity on hand
$177.7M
$1.8M
Total DebtLower is stronger
$788.2M
Stockholders' EquityBook value
$1.2B
$1.8B
Total Assets
$1.6B
$3.0B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
GPOR
GPOR
Q4 25
$177.7M
$1.8M
Q3 25
$258.0M
$3.4M
Q2 25
$253.6M
$3.8M
Q1 25
$217.7M
$5.3M
Q4 24
$319.6M
$1.5M
Q3 24
$155.1M
$3.2M
Q2 24
$177.1M
$1.2M
Q1 24
$204.7M
$8.2M
Total Debt
ACAD
ACAD
GPOR
GPOR
Q4 25
$788.2M
Q3 25
$691.7M
Q2 25
$695.2M
Q1 25
$700.4M
Q4 24
$702.9M
Q3 24
$694.4M
Q2 24
$679.5M
Q1 24
$636.4M
Stockholders' Equity
ACAD
ACAD
GPOR
GPOR
Q4 25
$1.2B
$1.8B
Q3 25
$917.3M
$1.8B
Q2 25
$822.4M
$1.8B
Q1 25
$765.2M
$1.7B
Q4 24
$732.8M
$1.7B
Q3 24
$577.2M
$2.1B
Q2 24
$516.7M
$2.1B
Q1 24
$464.0M
$2.2B
Total Assets
ACAD
ACAD
GPOR
GPOR
Q4 25
$1.6B
$3.0B
Q3 25
$1.3B
$2.9B
Q2 25
$1.2B
$3.0B
Q1 25
$1.1B
$2.9B
Q4 24
$1.2B
$2.9B
Q3 24
$976.9M
$3.2B
Q2 24
$914.1M
$3.2B
Q1 24
$855.1M
$3.3B
Debt / Equity
ACAD
ACAD
GPOR
GPOR
Q4 25
0.43×
Q3 25
0.38×
Q2 25
0.39×
Q1 25
0.42×
Q4 24
0.41×
Q3 24
0.34×
Q2 24
0.32×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
GPOR
GPOR
Operating Cash FlowLast quarter
$-48.7M
$185.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.18×
1.40×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
GPOR
GPOR
Q4 25
$-48.7M
$185.4M
Q3 25
$74.3M
$209.1M
Q2 25
$64.0M
$231.4M
Q1 25
$20.3M
$177.3M
Q4 24
$40.4M
$148.8M
Q3 24
$63.2M
$189.7M
Q2 24
$25.0M
$123.5M
Q1 24
$29.1M
$188.0M
Free Cash Flow
ACAD
ACAD
GPOR
GPOR
Q4 25
Q3 25
$73.9M
Q2 25
Q1 25
Q4 24
Q3 24
$63.2M
Q2 24
Q1 24
FCF Margin
ACAD
ACAD
GPOR
GPOR
Q4 25
Q3 25
26.5%
Q2 25
Q1 25
Q4 24
Q3 24
25.2%
Q2 24
Q1 24
Capex Intensity
ACAD
ACAD
GPOR
GPOR
Q4 25
Q3 25
0.1%
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
ACAD
ACAD
GPOR
GPOR
Q4 25
-0.18×
1.40×
Q3 25
1.03×
1.88×
Q2 25
2.40×
1.25×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
Q2 24
0.75×
Q1 24
1.76×
3.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

GPOR
GPOR

Natural Gas Production$296.9M75%
Other$42.7M11%
Naturalgasliquidsales$35.2M9%
Oil And Condensate$23.4M6%

Related Comparisons